PS:PC:Cholesterol(20:50:30 molar ratio)-based Fluoroliposome DiR

PS:PC:Cholesterol(20:50:30 molar ratio)-based Fluoroliposome DiR can be engineered to encapsulate therapeutic agents (such as chemotherapeutics) for targeted delivery, particularly to tumor tissues that can be recognized by the immune system.
The PS component enhances interactions with phagocytic cells, making these liposomes suitable for studies aimed at understanding phagocytosis and immune responses.
Fluoroliposomes labeled with DiR can be used for non-invasive imaging of biological processes. In vivo imaging studies using NIRF can provide insight into biodistribution, tumor targeting, and clearance processes.

msds of ps-pc-cholesterol-20-50-30-molar-ratio-based-fluoroliposome-dir